Evidence map›Paper›PMID 41898609›Full record

ArticleInternational journal of molecular sciences2026

In Situ Differential Analysis of α- and β-Glycosidase Activities in Lysosomes After Internalization Using Glucosylcerebroside-Based Liposomes.

Yi Wei, Osamu Kanie

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Yi WeiGraduate School of Science and Technology, Tokai University, Hiratsuka 259-1292, Kanagawa, Japan.
Osamu KanieGraduate School of Science and Technology, Tokai University, Hiratsuka 259-1292, Kanagawa, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fluorogenic glycosides are widely used substrates for assaying lysosomal glycosidase activities in vitro, but they do not provide subcellular information in living cells. In this study, we used glucosylceramide (GlcCer) liposomes as carriers to deliver fluorogenic substrates into live PC12 cells for confocal imaging. The α-4-methylumbelliferyl glucoside (α-4MUG) and β-glucosidase substrate β-4-(trifluoromethyl)umbelliferyl glucoside (β-4FMUG) were co-encapsulated in liposomes. The liposomes (approximately 100 nm in diameter) were taken up by PC12 cells after pulse exposure. Punctate fluorescence signals from both hydrolyzed substrates were observed. The relative intensity of two signals varied among puncta, as assessed by dual-channel imaging and line-scan analysis. These results show that GlcCer liposomes provide a practical platform for long-term and differential analyses of relative α- and β-glucosidase activities in living cells.

Indexed as

alpha-Glucosidasesbeta-GlucosidaseGlucosylceramidesGlycoside HydrolasesLiposomesLysosomesAnimalsGlucosidesHymecromoneMicroscopy, ConfocalPC12 CellsRatsalpha-Glucosidasesbeta-GlucosidaseGlucosidesGlucosylceramidesGlycoside HydrolasesHymecromoneLiposomes4-methylumbelliferone4-(trifluoromethyl)umbelliferoneconfocal imagingdifferential analysisfluorogenic glycosidesglucosylceramide (GlcCer)liposome

Identifiers

PMID41898609
PMCPMC13027016

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.